 multicenter comparison safety efficacy isradipine enalapril treatment hypertension multicenter trial efficacy safety isradipine enalapril patients essential hypertension Patients isradipine enalapril weeks placebo wash-out period weeks Dosage weeks basis blood pressure BP response remainder study Isradipine systolic diastolic BP mm Hg enalapril mm Hg between-treatment difference diastolic BP Overall isradipine responder rate patients entry BPs Fifteen enalapril-treated patients isradipine-treated patients treatment enalapril none isradipine withdrew lack efficacy adverse reactions headache dizziness edema isradipine group cough headache pain enalapril group drugs significant reductions BP study isradipine effective drugs